Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Michelle F Jacobs"'
Autor:
Michelle F Jacobs
Publikováno v:
eLife, Vol 10 (2021)
A new software package provides more accurate cancer risk prediction profiles and has the ability to integrate more genes and cancer types in the future.
Externí odkaz:
https://doaj.org/article/16aef25f932540d6a2b9f6e0c5143f69
Autor:
Shane C Quinonez, Bridget C O'Connor, Michelle F Jacobs, Atnafu Mekonnen Tekleab, Ayalew Marye, Delayehu Bekele, Beverly M Yashar, Erika Hanson, Abate Yeshidinber, Getahun Wedaje
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0255278 (2021)
BackgroundOver the past two decades non-communicable diseases (NCDs) have steadily increased as a cause of worldwide disability and mortality with a concomitant decrease in disease burden from communicable, maternal, neonatal and nutritional conditio
Externí odkaz:
https://doaj.org/article/5777e7f451944c409f15e9cba94845b1
Autor:
Nicole Trupiano, BS, Erika Koeppe, MS, Michelle F. Jacobs, MS, Tobias Else, MD, Kelly B. Cha, MD, PhD
Publikováno v:
JAAD Case Reports, Vol 31, Iss , Pp 42-45 (2023)
Externí odkaz:
https://doaj.org/article/9ea7ece04ddd49b991c968999c1ba972
Autor:
Tyler M, Seibert, Isla P, Garraway, Anna, Plym, Brandon A, Mahal, Veda, Giri, Michelle F, Jacobs, Heather H, Cheng, Stacy, Loeb, Brian T, Helfand, Rosalind A, Eeles, Todd M, Morgan
Publikováno v:
European Urology. 83:241-248
Prostate cancer (PCa) is a leading cause of death and partially heritable. Genetic risk prediction might be useful for strategies to reduce PCa mortality through early detection and prevention.To review evidence for genetic risk prediction for PCa.A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1d96920ca38c213164b030d8ce6f90e
https://doi.org/10.1016/j.eururo.2022.12.021
https://doi.org/10.1016/j.eururo.2022.12.021
Publikováno v:
Cancer Genetics. :15-18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f14eac3878069cfc44366dd0c5a8f15
https://doi.org/10.1016/j.cancergen.2022.05.039
https://doi.org/10.1016/j.cancergen.2022.05.039
Autor:
Kelly M. Bailey, Linda M. McAllister-Lucas, Peter C. Lucas, Rajen Mody, Katherine A. Janeway, Kurt Weiss, Nivitha Periyapatna, Haley Raphael, Chandan Kumar-Sinha, Michelle F. Jacobs, Nathanael G. Bailey, Claire M. Julian, Rosemarie E. Venier, Elina Mukherjee, Jessica D. Daley, Lisa M. Maurer
Loss of GBP1 expression does not impact PSaRC318 cell migration.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::350842c1693c4a74b6a8acb40a758cf3
https://doi.org/10.1158/2767-9764.22544712
https://doi.org/10.1158/2767-9764.22544712
Autor:
Kelly M. Bailey, Linda M. McAllister-Lucas, Peter C. Lucas, Rajen Mody, Katherine A. Janeway, Kurt Weiss, Nivitha Periyapatna, Haley Raphael, Chandan Kumar-Sinha, Michelle F. Jacobs, Nathanael G. Bailey, Claire M. Julian, Rosemarie E. Venier, Elina Mukherjee, Jessica D. Daley, Lisa M. Maurer
Prevalence of somatic DNA damage repair gene variants in Ewing cell lines included in original studies of PARP inhibition.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71c9e36d9ddb5b10558a98c6dcb4644f
https://doi.org/10.1158/2767-9764.22544706.v1
https://doi.org/10.1158/2767-9764.22544706.v1
Autor:
Kelly M. Bailey, Linda M. McAllister-Lucas, Peter C. Lucas, Rajen Mody, Katherine A. Janeway, Kurt Weiss, Nivitha Periyapatna, Haley Raphael, Chandan Kumar-Sinha, Michelle F. Jacobs, Nathanael G. Bailey, Claire M. Julian, Rosemarie E. Venier, Elina Mukherjee, Jessica D. Daley, Lisa M. Maurer
Ewing sarcoma is a fusion oncoprotein–driven primary bone tumor. A subset of patients (∼10%) with Ewing sarcoma are known to harbor germline variants in a growing number of genes involved in DNA damage repair. We recently reported our discovery o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fa78735420778b69b3aa79e2eb85561
https://doi.org/10.1158/2767-9764.c.6550734
https://doi.org/10.1158/2767-9764.c.6550734
Autor:
Alison M. Mondul, Mallory Luke, Samuel D. Kaffenberger, Leander Van Neste, Bumsoo Park, Elena M. Stoffel, Simpa S. Salami, Michael Sessine, Michelle F. Jacobs, Amy Kasputis, Todd M. Morgan, Kara J. Milliron, Marissa Solorzano, Sofia D. Merajver, Deborah R. Kaye, Erin F. Cobain, Laura Caba, Randy Vince, Tudor Borza, Sanjay Das
Publikováno v:
Urology. 156:96-103
Objective To improve prostate cancer screening for high-risk men, we developed an early detection clinic for patients at high genetic risk of developing prostate cancer. Despite the rapidly growing understanding of germline variants in driving aggres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2239439428ce5d45bcd8fdfd79627837
https://doi.org/10.1016/j.urology.2021.05.078
https://doi.org/10.1016/j.urology.2021.05.078
Publikováno v:
Familial Cancer. 21:375-385
Advances in cancer genetics have increased germline pathogenic/likely pathogenic variant (PV/LPV) detection rates. More data is needed to inform which patients with previously uninformative results could benefit most from retesting, especially beyond
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41e6ceb95657be35e80ee665d3ade58a
https://doi.org/10.1007/s10689-021-00276-8
https://doi.org/10.1007/s10689-021-00276-8